bethanechol has been researched along with Disease Exacerbation in 2 studies
Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Four patients meeting the clinical criteria for Alzheimer disease, enrolled in a pilot study for the evaluation of response to intracerebroventricular administration of bethanechol chloride." | 5.09 | Progression of clinical deterioration and pathological changes in patients with Alzheimer disease evaluated at biopsy and autopsy. ( Cummings, JL; Di Patre, PL; Read, SL; Secor, DL; Tomiyasu, U; Vartavarian, LM; Vinters, HV, 1999) |
| "Chronic relapsing experimental autoimmune encephalomyelitis was induced in mice." | 1.35 | Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with high-resolution ultrasonography. ( Al-Izki, S; Baker, D; Giovannoni, G; Pryce, G, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Izki, S | 1 |
| Pryce, G | 1 |
| Giovannoni, G | 1 |
| Baker, D | 1 |
| Di Patre, PL | 1 |
| Read, SL | 1 |
| Cummings, JL | 1 |
| Tomiyasu, U | 1 |
| Vartavarian, LM | 1 |
| Secor, DL | 1 |
| Vinters, HV | 1 |
1 trial available for bethanechol and Disease Exacerbation
| Article | Year |
|---|---|
Progression of clinical deterioration and pathological changes in patients with Alzheimer disease evaluated at biopsy and autopsy.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Antigens, CD; Antigens, Differentiation, Myelomonocy | 1999 |
1 other study available for bethanechol and Disease Exacerbation
| Article | Year |
|---|---|
Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with high-resolution ultrasonography.
Topics: Animals; Bethanechol; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Mice | 2009 |